
Loading, please wait...

Loading, please wait...

Photodynamic therapy (PDT) represents a promising frontier in modern oncology. This strategy utilizes photosensitizers that light exposure activates to trigger targeted cytotoxic reactions. However, traditional two-dimensional cell cultures often fail to replicate the complex human intestinal microenvironment. Consequently, researchers have developed a novel gut-on-a-chip for PDT evaluation that simulates realistic physiological features. This microsystem precisely mimics mechanical shear stress and structural intestinal villi to provide more reliable data.
The newly developed microdevice generates controlled fluidic flow to recreate the natural forces within the human gut. Unlike static models, this low shear stress environment promotes rapid polarization of intestinal epithelial cells. Because of this mechanical stimulation, the cells spontaneously form folds that closely resemble human intestinal villi. Notably, the study found that this 3D model exhibited significantly reduced cell viability after therapy compared to conventional methods. Therefore, the presence of a physiologically relevant structure directly influences the perceived efficacy of photosensitizers.
Furthermore, this system incorporates representative intestinal microbes to simulate a microbiota-relevant context. The gut-on-a-chip for PDT allows scientists to observe how bacterial populations interact with photosensitizers during treatment. This integration is vital because the intestinal flora can modulate drug responses and influence therapeutic outcomes. Additionally, the platform features tunable light simulation and spatial resolution for high-precision analysis. Collectively, these advancements offer an analytically tractable platform for evaluating cancer treatments in a complex environment.
It is a microfluidic device that mimics the structural, mechanical, and functional properties of the human intestine in a laboratory setting.
The microenvironment, including shear stress and 3D architecture, significantly affects how cells respond to photosensitizers and light, making 2D models less accurate.
Including microbes allows researchers to study the interactions between the gut flora and the therapy, providing a more realistic prediction of clinical results.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Liu X et al. An Integrated Gut-on-a-Chip System for the Evaluation of Photosensitizers under Complex Microenvironmental Conditions. Anal Chem. 2026 Jun 01. doi: 10.1021/acs.analchem.6c01450. PMID: 42226032.
Jalili-Firoozinezhad S et al. A complex human gut-on-a-chip to replicate the intestinal microenvironment. Nat Biomed Eng. 2019;3(7):520-531.
Kim HJ et al. Human gut-on-a-chip for studying host-microbiome interactions. Proc Natl Acad Sci USA. 2012;109(22):E1410-1418.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A novel gut-on-a-chip system mimics the human intestine's structure and microbiota to enhance the evaluation of photosensitizers for cancer therapy....
4 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today